Today, HIMS stock has experienced a notable decline of 8%, as reported by price data from Polygon. The total trading volume reached approximately $1.47 billion, indicating a significant level of market activity.
Insider Trading Activity of HIMS
In the past six months, insider trading related to HIMS has been quite one-sided. The company’s executives reported 97 trades, all being sales, with no purchases recorded. Here’s a detailed look at the insider trading activities:
- Andrew Dudum (CEO): 0 purchases, 44 sales, 1,844,186 shares sold, estimated total: $92,221,853.
- Oluyemi Okupe (CFO): 0 purchases, 12 sales, 357,758 shares sold, estimated total: $19,392,916.
- Michael Chi (CCO): 0 purchases, 12 sales, 90,501 shares sold, estimated total: $5,358,413.
- Patrick Harrison Carroll (CMO): 0 purchases, 2 sales, 70,021 shares sold, estimated total: $3,720,938.
- Melissa Baird (COO): 0 purchases, 10 sales, 100,003 shares sold, estimated total: $3,637,319.
- Soleil Boughton (CLO): 0 purchases, 13 sales, 39,096 shares sold, estimated total: $1,955,072.
- Irene Becklund (PAO): 0 purchases, 4 sales, 24,902 shares sold, estimated total: $1,280,807.
Hedge Fund Activity
The trading actions of institutional investors concerning HIMS stock have been varied in recent months. A total of 311 institutional investors increased their holdings, while 194 reduced their positions. Here’s a snapshot of the significant moves:
- Capital World Investors: Added 18,559,302 shares.
- D. E. Shaw & Co., Inc: Removed 4,143,604 shares, a drop of 68.7%.
- Invesco Ltd: Added 2,128,587 shares.
- Contrarius Group Holdings Ltd: Removed 1,749,968 shares, a complete exit.
- Clear Street LLC: Added 1,676,667 shares.
- Norges Bank: Added 1,574,009 shares.
- Bank of Montreal: Added 1,515,809 shares, marking a 5701.5% increase.
Congressional Trading Insights
In the past six months, members of Congress have engaged in HIMS stock trading once. This singular transaction involved a purchase, with no reported sales during this period.
Analyst Ratings and Price Targets
Recent ratings from Wall Street analysts reveal a mixed outlook for HIMS stock. Here are the highlights:
- Buy Ratings: 1 firm has issued a buy rating.
- Sell Ratings: 2 firms have issued sell ratings.
Analysts provided various price targets for HIMS, with the median target set at $38.00. Noteworthy targets include:
- Maria Ripps (Canaccord Genuity): $68.00 on 09/12/2025.
- Jailendra Singh (Truist Securities): $37.00 on 08/18/2025.
- Craig Hettenbach (Morgan Stanley): $40.00 on 06/11/2025.
- Ryan MacDonald (Needham): $65.00 on 06/04/2025.
For ongoing insights and updates on HIMS stock performance, investors can monitor the latest data on El-Balad.
